TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

1.60$ -6.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Tvardi Therapeutics, Inc. (TVRD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.2% of the shares are freely tradable; institutional investors hold 28.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 28.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 34.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 13Mio.

Largest Shareholders

Institutions

Institutions TVRD
Name Stake (%) Shares Change (%) Date
Slate Path Capital LP 5.28 704,118 +0.0 06/30/2026
BlackRock Inc 2.91 388,075 -0.7 03/31/2026
Vanguard Capital Management, LLC 2.58 344,708 +0.0 03/31/2026
American Financial Group Inc 1.68 223,659 +0.0 06/30/2026
Geode Capital Management, LLC 1.37 182,339 +16.0 03/31/2026
Silvercrest Asset Management Group LLC 0.76 101,034 +0.0 03/31/2026
State Street Corp 0.73 97,231 -15.8 03/31/2026
Renaissance Technologies Corp 0.69 92,100 -11.9 03/31/2026

Funds

Funds TVRD
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.94 258,426 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.64 85,956 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?